These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 627405)

  • 41. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
    Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
    Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1990 Dec; 42(12):531-6. PubMed ID: 2087226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)].
    Chamot E; Toscani L; Egger P; Germann D; Bourquin C
    Rev Epidemiol Sante Publique; 1998 Mar; 46(2):100-7. PubMed ID: 9592852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
    Yadav S; Thukral R; Chakarvarti A
    Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Jeryl Lynn strain live mumps virus vaccine. Durable immunity for three years following vaccination.
    Weibel RE; Buynak EB; Whitman JE; Leagus MB; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(9):1667-70. PubMed ID: 5818350
    [No Abstract]   [Full Text] [Related]  

  • 47. Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus.
    Christenson B; Böttiger M
    Biologicals; 1990 Jul; 18(3):213-9. PubMed ID: 2257134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation in young children of the Urabe Am 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain.
    Vesikari T; André FE; Simoen E; Florent G; Ala-Laurila EL; Heikkinen A; Kuusinen H; Terho A
    Acta Paediatr Scand; 1983 Jan; 72(1):37-40. PubMed ID: 6344550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a live attenuated mumps vaccine (Jeryl Lynn). With observations on the optimal time for testing serologic response.
    Brunell PA; Brickman A; Steinberg S
    Am J Dis Child; 1969 Sep; 118(3):435-40. PubMed ID: 5812074
    [No Abstract]   [Full Text] [Related]  

  • 50. Jeryl Lynn Strain Live Attenuated Mumps Virus vaccine in a private pediatric practice.
    Nickey LN; Huchton P; McGee WG
    South Med J; 1970 Mar; 63(3):306-8. PubMed ID: 4905918
    [No Abstract]   [Full Text] [Related]  

  • 51. A NATIONWIDE SERUM SURVEY OF UNITED STATES MILITARY RECRUITS, 1962. 3. MEASLES AND MUMPS ANTIBODIES.
    BLACK FL
    Am J Hyg; 1964 Nov; 80():304-7. PubMed ID: 14225920
    [No Abstract]   [Full Text] [Related]  

  • 52. [Results of studying a live mumps vaccine from strain L-3 manufactured by the Moscow Research Institute of Viral Preparations. The reactogenic and antigenic properties of the vaccine].
    Unanov SS; Bochkov RA; Alekseeva AK; Kaptsova TI; Levchenko EN
    Vopr Virusol; 1977; (1):54-8. PubMed ID: 333761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infants' responses to live, attenuated, B level, Jeryl Lynn mumps vaccine.
    Wilkins J; Williams FF; Wehrle PF
    Am J Dis Child; 1972 Jul; 124(1):66-7. PubMed ID: 5033752
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.
    Connaughton SM; Wheeler JX; Vitková E; Minor P; Schepelmann S
    Vaccine; 2015 Aug; 33(36):4586-93. PubMed ID: 26187256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plaque formation by mumps virus and inhibition by antiserum.
    Flanagan TD; Barron AL
    Appl Microbiol; 1970 Feb; 19(2):360-6. PubMed ID: 4985434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of the correlation between neutralization tests and hemagglutination inhibition tests in determinations of mumps virus antibodies].
    Popov VF; Kulish EA; Iunasova TN
    Vopr Virusol; 1975; (3):360-3. PubMed ID: 1162959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serological evaluation of measles virus (Schwarz strain), mumps virus (Jeryl Lynn strain) and rubella virus (Cendehill strain) combination vaccines.
    Schell K; Kenny MT; Jackson JE
    J Biol Stand; 1975; 3(2):231-9. PubMed ID: 1126967
    [No Abstract]   [Full Text] [Related]  

  • 58. Jeryl Lynn strain live attenuated mumps virus vaccine. Durability of immunity following administration.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    JAMA; 1968 Jan; 203(1):14-8. PubMed ID: 5694077
    [No Abstract]   [Full Text] [Related]  

  • 59. STUDIES ON RAPID IMMUNIZATION WITH MUMPS VACCINE.
    FRIEDMAN RM; HOLTZ AI; BARON S; SILBERGELD S; BUCKLER CE
    Am J Hyg; 1963 Nov; 78():269-74. PubMed ID: 14071349
    [No Abstract]   [Full Text] [Related]  

  • 60. Experimental-scale measles and mumps vaccine production on microcarrier-grown cells.
    Sidorenko ES; Dorofeeva LV; Kaptsova TI; Steinberg LL; Zasorina IN; Sinitsyna OA; Boriskin YuS
    Vaccine; 1989 Dec; 7(6):554-6. PubMed ID: 2609729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.